mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0001 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |